Pattern of Acute Antipsychotic Drug- Toxicity in Children
NCT06125275 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2023-11-09
Summary
Pattern of Acute Antipsychotic Drug- Toxicity in Children at Assiut University Children Hospital.
* Determine the pattern and outcome of acute antipsychotic drug- toxicity of children who are admitted to The emergency department of Assiut University Children Hospital (AUCH).
* Estimate prevalence of acute antipsychotics drug-toxicity in children and adolescents at AUCH.
Conditions
- Antipsychotic Drug- Toxicity
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Month
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-30
- Primary Completion
- 2025-12-31
- Completion
- 2026-02-28
More Related Trials
-
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
NCT00457366 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Drug Monitoring in Child and Adolescent Psychiatry
NCT01057329 ·Status: COMPLETED
-
Efficacy of SMOF Lipid in the Management of Acute Poisoning With Clozapine
NCT06413589 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
NCT03110900 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567 ·Status: TERMINATED ·Phase: PHASE3
-
Ketamine IV Classic Protocol : Five Years Follow up
NCT04824157 ·Status: COMPLETED
-
Acute and Chronic Toxicity of Some Synthetic Cannabinoids in Assiut Psychiatric Hospitals
NCT03866941 ·Status: UNKNOWN
-
Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
NCT02824627 ·Status: COMPLETED ·Phase: PHASE2
-
Haloperidol vs. Valproate in Agitation
NCT01750541 ·Status: COMPLETED ·Phase: PHASE3
-
Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin
NCT03011970 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
NCT07246187 ·Status: RECRUITING ·Phase: PHASE3
-
Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
NCT02710084 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of a multicOmpoNent Behavioural intervenTion to Reduce endocrINe disrUptor Exposure During pErinatal Period (CONTINUE)
NCT07142447 ·Status: RECRUITING ·Phase: NA
-
PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdel
NCT03199950 ·Status: UNKNOWN ·Phase: PHASE4
-
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
NCT02643355 ·Status: COMPLETED ·Phase: NA
-
Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients
NCT00184184 ·Status: COMPLETED
-
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
NCT06160284 ·Status: RECRUITING ·Phase: PHASE1
-
GABA Pathways in Autism Spectrum Disorder (ASD)
NCT03678129 ·Status: COMPLETED ·Phase: NA
-
TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting
NCT03639558 ·Status: COMPLETED ·Phase: PHASE4
-
Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use
NCT03648684 ·Status: COMPLETED ·Phase: NA
-
Psychoactive Drug Uses Among Medical and Pharmacy Students
NCT05115981 ·Status: COMPLETED
-
Acute Agitation in Emergency Psychiatry
NCT06752616 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Characterization of the Prosocial and Prosexual Effects of GHB
NCT02342366 ·Status: COMPLETED ·Phase: NA
-
Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents
NCT04336605 ·Status: UNKNOWN
-
Correlation Between Immune Metabolism in Patients With Benzodiazepine Poisoning and Patients'Mental Disorders
NCT05184959 ·Status: UNKNOWN